Patents by Inventor Marc Hendriks

Marc Hendriks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190207182
    Abstract: An energy supply device for underwater use includes at least one first housing. The energy supply device includes a multiplicity of electrochemical cells, wherein the energy supply device includes at least one first electrical jack connection on the outer side of the first housing. The first housing of the energy supply device is filled bubble-free with a low-compressibility fluid. The first housing includes a filling device for filling with the low-compressibility fluid and a discharge device for discharging the low-compressibility fluid. The first housing includes a pressure compensation device.
    Type: Application
    Filed: August 21, 2017
    Publication date: July 4, 2019
    Applicants: THYSSENKRUPP MARINE SYSTEMS GMBH, thyssenkrupp AG
    Inventors: Christian FRÜHLING, Marc SCHIEMANN, Willem Hendrik WEHNER
  • Publication number: 20190177078
    Abstract: A capsule containing a substance for the preparation of a potable beverage. The capsule comprises an aluminum capsule body having a side wall and an outwardly extending flange. The capsule is hermetically closed by an aluminum cover attached to the outwardly extending flange. The capsule further comprises a sealing member at the outwardly extending flange for providing a fluid sealing contact with an enclosing member of a beverage preparation device. The capsule further comprises an elastic support structure, which is attached to an outer cover surface of said cover. In a condition, in which the capsule is freely resting with said elastic support structure on a fully straight reference surface, the elastic support structure provides a spacing between the outwardly extending flange and said reference surface, said spacing being constant all around in the circumferential capsule direction.
    Type: Application
    Filed: November 12, 2018
    Publication date: June 13, 2019
    Applicant: Koninklijke Douwe Egberts B.V.
    Inventors: Hielke Dijkstra, Erik Pieter Van Gaasbeek, Ralf Kamerbeek, Arend Hendrik Groothornte, Marc Hendrikus Joseph Ottenschot
  • Publication number: 20130131805
    Abstract: The invention is directed to an orthopedic implant comprising different distinct sections, wherein each section comprises a different polymeric material and the polymeric materials are at the contact surfaces of the sections attached to each other by chemical bonds and/or physical interaction and to a method for the production of an orthopedic implant wherein multi-component molding is used.
    Type: Application
    Filed: February 9, 2011
    Publication date: May 23, 2013
    Inventors: Marc Hendriks, Detlef Olaf Alexander Schumann, Eva Wisse
  • Patent number: 7767652
    Abstract: Medical devices and methods for reducing localized fibrosis at the site of the medical device.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: August 3, 2010
    Assignee: Medtronic, Inc.
    Inventor: Marc Hendriks
  • Publication number: 20100034794
    Abstract: Methods and compositions are provided for inducing neovascularization in injured tissues with endothelial progenitor cells (EPCs). Mixtures of purified CD34+ endothelial progenitors and purified CD14+ monocytes, or products of an in vitro co-culture of purified CD34+ endothelial progenitor cells and purified CD14+ monocytes provide neovascularization after administration to a subject having a tissue injury, such as an ischemic injury.
    Type: Application
    Filed: October 2, 2007
    Publication date: February 11, 2010
    Inventors: Barry W.A. van der Strate, Guido Krenning, Brian C.A. Fernandes, Martin Harmsen, Marja J.A. van Luyn, Didier Billy, Marc Hendriks
  • Patent number: 7582068
    Abstract: An occlusion resistant medical shunt, particularly a hydrocephalic shunt, is provided for implantation into a mammal. The shunt has an elongate wall structure configured as a tube having a lumen therethrough and a proximal end for receipt of bodily fluids. The bodily fluids, such as cerebrospinal fluid, flows through the shunt to a distal end for discharge of the bodily fluids. The wall structure of the shunt generally includes a biocompatible medical device material. The shunts of the present invention further include one or more occlusion resistant materials to resist occlusion of the lumenal passage in the shunt.
    Type: Grant
    Filed: February 18, 2004
    Date of Patent: September 1, 2009
    Assignee: Medtronic, Inc.
    Inventors: Edouard Koullick, Marc Hendriks, William Bertrand
  • Publication number: 20080208312
    Abstract: An endoluminal stent graft includes segments of a healing promoter to promote the “healing in” of the distal and/or proximal neck(s) of the endoluminal stent graft in a vessel, thus reducing the risk of migration and the occurrence of endoleaks that can formed at the side of the neck(s) and the consequent feeding of the aneurysm sac. In some applications, the segments of the healing promoter are located within a proximal anchor region located near the proximal neck opening of the endoluminal stent graft and, optionally, within one or more distal anchor regions located near one or more distal neck openings of the endoluminal stent graft. In other applications, the segments of the healing promoter are located within the proximal anchor region, but not the distal anchor region.
    Type: Application
    Filed: August 15, 2006
    Publication date: August 28, 2008
    Applicant: Medtronic Vascular, Inc.
    Inventors: Brian Kwitkin, Didier Billy, Marc Hendriks
  • Publication number: 20070239267
    Abstract: An endoluminal stent graft includes a healing-promoting material to enhance the “healing” of the proximal and/or distal neck(s) of the endoluminal stent graft and the vessel wall; the risk of migration and the occurrence of Type 1 endoleaks is reduced. The healing-promoting material is located within a proximal anchor region located near the proximal neck opening of the endoluminal stent graft and optionally within one or more distal anchor regions located near one or more distal neck openings of the endoluminal stent graft.
    Type: Application
    Filed: March 28, 2006
    Publication date: October 11, 2007
    Applicant: Medtronic Vascular, Inc.
    Inventors: Marc Hendriks, Edouard Koullick, Jeff Elkins, Didier Billy, Brian Kwitkin, Paul Van Bilsen, Jack Chu, Brian Raze
  • Publication number: 20070098703
    Abstract: The present invention encompasses methods and apparatus for minimizing the risks inherent in endovascular grafting for aneurysm repair. The invention includes tracking a delivery means into an aneurismal site and deploying a stent graft in the aneurysmal site along side the delivery means. Next, adipocytes derived from adipose tissue are delivered to the aneurysmal site.
    Type: Application
    Filed: November 29, 2006
    Publication date: May 3, 2007
    Applicant: Medtronic Vascular, Inc.
    Inventors: Marc Hendriks, Brian Kwitkin
  • Publication number: 20070087059
    Abstract: Bioactive delivery matrix compositions and methods of making and using such compositions.
    Type: Application
    Filed: October 17, 2005
    Publication date: April 19, 2007
    Inventors: Frank Everaerts, Marc Hendriks, Mirian Gillissen
  • Patent number: 7176261
    Abstract: Medical devices with polymer coatings designed to control the release of angiotensin-(1-7) receptor agonists from medical devices are disclosed. The present application also discloses providing vascular stents with angiotensin-(1-7) receptor agonist-containing controlled-release coatings. Methods for treating or inhibiting post-stent implantation restenosis as well as improving vascular endothelial function in patients are also provided.
    Type: Grant
    Filed: October 21, 2005
    Date of Patent: February 13, 2007
    Assignee: Medtronic, Inc.
    Inventors: Edze Jan Tijsma, Anita Driessen-Levels, Marc Hendriks
  • Patent number: 7053051
    Abstract: Methods for making crosslinked material, such as collagen-based material, and bioprosthetic devices. The crosslinked material includes hydroxyl groups, carboxyl groups, and amine groups prior to crosslinking. The methods include removing at least a portion of the zero-length ester crosslinks in a crosslinked material and/or blocking at least a portion of the amine groups that are reactive with carboxyl groups and form zero-length crosslinks.
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: May 30, 2006
    Assignee: Medtronic, Inc.
    Inventors: Marc Hendriks, Frank Everaerts, Mirian Gillissen, Michel Verhoeven, Mark W. Torrianni
  • Publication number: 20060088572
    Abstract: Medical devices with polymer coatings designed to control the release of angiotensin-(1-7) receptor agonists from medical devices are disclosed. The present application also discloses providing vascular stents with angiotensin-(1-7) receptor agonist-containing controlled-release coatings. Methods for treating or inhibiting post-stent implantation restenosis as well as improving vascular endothelial function in patients are also provided.
    Type: Application
    Filed: October 21, 2005
    Publication date: April 27, 2006
    Applicant: Medtronic, Inc.
    Inventors: Edze Tijsma, Anita Driessen-Levels, Marc Hendriks
  • Publication number: 20060035290
    Abstract: A method is provided for the isolation of endothelial progenitor cells from a source of progenitor cells by isolating a population of lineage-negative cells and further isolating CD34+ cells from the lineage-negative population by fluorescence-activated cell sorting. Isolated populations of endothelial progenitor cells and therapeutic compositions containing CD34+ cells for the induction of blood vessels, induction of angiogenic responses in surrounding blood vessels and the chemotaxis of inflammatory cells are also provided.
    Type: Application
    Filed: August 11, 2005
    Publication date: February 16, 2006
    Applicant: Medtronic, Inc.
    Inventors: Eliane Popa, Martin Harmsen, Barry van der Strate, Marja van Luyn, Marc Hendriks
  • Publication number: 20060030538
    Abstract: Methods for reducing or preventing localized fibrosis in a localized tissue region using SiRNA technology.
    Type: Application
    Filed: July 18, 2005
    Publication date: February 9, 2006
    Applicant: Medtronic, Inc.
    Inventor: Marc Hendriks
  • Publication number: 20060029636
    Abstract: Medical devices and methods for reducing localized fibrosis at the site of the medical device.
    Type: Application
    Filed: July 18, 2005
    Publication date: February 9, 2006
    Applicant: Medtronic, Inc.
    Inventor: Marc Hendriks
  • Publication number: 20050136510
    Abstract: Methods for making crosslinked material, such as collagen-based material, and bioprosthetic devices. The crosslinked material includes hydroxyl groups, carboxyl groups, and amine groups prior to crosslinking. The methods include removing at least a portion of the zero-length ester crosslinks in a crosslinked material and/or blocking at least a portion of the amine groups that are reactive with carboxyl groups and form zero-length crosslinks.
    Type: Application
    Filed: October 27, 2004
    Publication date: June 23, 2005
    Inventors: Marc Hendriks, Frank Everaerts, Mirian Gillissen, Michel Verhoeven, Mark Torrianni
  • Patent number: 6887485
    Abstract: Biocompatible metallic medical devices having silanized surfaces coupled to nucleophile residues that release sustained, therapeutic amounts of nitric oxide to specific sites within a mammalian body are provided. Additionally, the biocompatible metallic medical devices can also be provided with anti-thrombogenic, lubricious coatings that release sustained, therapeutic amounts of nitric oxide. Moreover, the silanized metallic devices are surprisingly durable when exposed to harsh chemical methods often needed to bind nitric oxide-releasing functional groups to nucleophile residues. Furthermore, methods are provided for producing stable, silanized, sustained nitric oxide-releasing metallic medical devices.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: May 3, 2005
    Assignees: Medtronic Vascular, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Anthony L. Fitzhugh, Peiwen Cheng, Joseph Saavedra, Robert Cafferata, Marc Hendriks, Larry K. Keefer, Eugene Tedeschi, Michel I. P. M. Verhoeven
  • Publication number: 20040220510
    Abstract: An occlusion resistant medical shunt, particularly a hydrocephalic shunt, is provided for implantation into a mammal. The shunt has an elongate wall structure configured as a tube having a lumen therethrough and a proximal end for receipt of bodily fluids. The bodily fluids, such as cerebrospinal fluid, flows through the shunt to a distal end for discharge of the bodily fluids. The wall structure of the shunt generally includes a biocompatible medical device material. The shunts of the present invention further include one or more occlusion resistant materials to resist occlusion of the lumenal passage in the shunt.
    Type: Application
    Filed: February 18, 2004
    Publication date: November 4, 2004
    Inventors: Edouard Koullick, Marc Hendriks, William Bertrand
  • Patent number: 6812217
    Abstract: The present invention provides a medical device that includes a carrier and a polynucleotide, where the carrier has a surface that includes a polymer with which the polynucleotide is associated. In another aspect, the present invention provides a medical device that includes a carrier and a cell that expresses an antimicrobial peptide, where the carrier has a surface that includes a polymer with which the cell is associated. The present invention further provides methods of making and using medical devices that include a carrier and a polynucleotide or a cell.
    Type: Grant
    Filed: December 4, 2000
    Date of Patent: November 2, 2004
    Assignee: Medtronic, Inc.
    Inventor: Marc Hendriks